Literature DB >> 18566411

Activation of the JAK/STAT-1 signaling pathway by IFN-gamma can down-regulate functional expression of the MHC class I-related neonatal Fc receptor for IgG.

Xindong Liu1, Lilin Ye, Yu Bai, Habi Mojidi, Neil E Simister, Xiaoping Zhu.   

Abstract

Expression of many MHC genes is enhanced at the transcriptional or posttranscriptional level following exposure to the cytokine IFN-gamma. However, in this study we found that IFN-gamma down-regulated the constitutive expression of the neonatal Fc receptor (FcRn), an MHC class I-related molecule that functions to transport maternal IgG and protect IgG and albumin from degradation. Epithelial cell, macrophage-like THP-1 cell, and freshly isolated human PBMC exposure to IFN-gamma resulted in a significant decrease of FcRn expression as assessed by real-time RT-PCR and Western blotting. The down-regulation of FcRn was not caused by apoptosis or the instability of FcRn mRNA. Chromatin immunoprecipitation and gel mobility shift assays showed that STAT-1 bound to an IFN-gamma activation site in the human FcRn promoter region. Luciferase expression from an FcRn promoter-luciferase reporter gene construct was not altered in JAK1- and STAT-1-deficient cells following exposure to IFN-gamma, whereas expression of JAK1 or STAT-1 protein restored the IFN-gamma inhibitory effect on luciferase activity. The repressive effect of IFN-gamma on the FcRn promoter was selectively reversed or blocked by mutations of the core nucleotides in the IFN-gamma activation site sequence and by overexpression of the STAT-1 inhibitor PIAS1 or the dominant negative phospho-STAT-1 mutations at Tyr-701 and/or Ser-727 residues. Furthermore, STAT-1 might down-regulate FcRn transcription through sequestering the transcriptional coactivator CREB binding protein/p300. Functionally, IFN-gamma stimulation dampened bidirectional transport of IgG across a polarized Calu-3 lung epithelial monolayer. Taken together, our results indicate that the JAK/STAT-1 signaling pathway was necessary and sufficient to mediate the down-regulation of FcRn gene expression by IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566411      PMCID: PMC2667120          DOI: 10.4049/jimmunol.181.1.449

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  74 in total

1.  IFN-dependent down-regulation of the NKG2D ligand H60 on tumors.

Authors:  Jack D Bui; Leonidas N Carayannopoulos; Lewis L Lanier; Wayne M Yokoyama; Robert D Schreiber
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

2.  FcRn: an IgG receptor on phagocytes with a novel role in phagocytosis.

Authors:  Gestur Vidarsson; Annette M Stemerding; Nigel M Stapleton; Suzanne E Spliethoff; Hans Janssen; Frank E Rebers; Masja de Haas; Jan G van de Winkel
Journal:  Blood       Date:  2006-07-18       Impact factor: 22.113

3.  FcgammaRIII-dependent inhibition of interferon-gamma responses mediates suppressive effects of intravenous immune globulin.

Authors:  Kyung-Hyun Park-Min; Natalya V Serbina; Wentian Yang; Xiaojing Ma; Gerald Krystal; Benjamin G Neel; Stephen L Nutt; Xiaoyu Hu; Lionel B Ivashkiv
Journal:  Immunity       Date:  2007-01       Impact factor: 31.745

4.  The level of IgE produced by a B cell is regulated by norepinephrine in a p38 MAPK- and CD23-dependent manner.

Authors:  Georg Pongratz; Jaclyn W McAlees; Daniel H Conrad; Robert S Erbe; Karen M Haas; Virginia M Sanders
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

5.  Protective role of IFN-gamma in collagen-induced arthritis conferred by inhibition of mycobacteria-induced granulocyte chemotactic protein-2 production.

Authors:  Hilde Kelchtermans; Sofie Struyf; Bert De Klerck; Tania Mitera; Marijke Alen; Lies Geboes; Maarten Van Balen; Chris Dillen; Willy Put; Conny Gysemans; Alfons Billiau; Jo Van Damme; Patrick Matthys
Journal:  J Leukoc Biol       Date:  2007-01-02       Impact factor: 4.962

6.  STAT1-independent inhibition of cyclooxygenase-2 expression by IFNgamma; a common pathway of IFNgamma-mediated gene repression but not gene activation.

Authors:  L Klampfer; J Huang; P Kaler; T Sasazuki; S Shirasawa; L Augenlicht
Journal:  Oncogene       Date:  2006-10-02       Impact factor: 9.867

7.  A novel c-Jun-dependent signal transduction pathway necessary for the transcriptional activation of interferon gamma response genes.

Authors:  Daniel J Gough; Kanaga Sabapathy; Enoch Yi-No Ko; Helen A Arthur; Robert D Schreiber; Joseph A Trapani; Christopher J P Clarke; Ricky W Johnstone
Journal:  J Biol Chem       Date:  2006-11-14       Impact factor: 5.157

8.  Interferon-gamma-activated STAT-1alpha suppresses MMP-9 gene transcription by sequestration of the coactivators CBP/p300.

Authors:  Zhendong Ma; Mi Jung Chang; Reesha C Shah; Etty N Benveniste
Journal:  J Leukoc Biol       Date:  2005-05-13       Impact factor: 4.962

9.  Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease.

Authors:  Stefka B Petkova; Shreeram Akilesh; Thomas J Sproule; Gregory J Christianson; Hana Al Khabbaz; Aaron C Brown; Leonard G Presta; Y Gloria Meng; Derry C Roopenian
Journal:  Int Immunol       Date:  2006-10-31       Impact factor: 4.823

10.  STAT-1-mediated repression of monocyte interleukin-10 gene expression in vivo.

Authors:  Jeffrey B VanDeusen; Manisha H Shah; Brian Becknell; Bradley W Blaser; Amy K Ferketich; Gerard J Nuovo; Brian M M Ahmer; Joan Durbin; Michael A Caligiuri
Journal:  Eur J Immunol       Date:  2006-03       Impact factor: 5.532

View more
  26 in total

Review 1.  FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin.

Authors:  Michal Pyzik; Timo Rath; Wayne I Lencer; Kristi Baker; Richard S Blumberg
Journal:  J Immunol       Date:  2015-05-15       Impact factor: 5.422

Review 2.  Chapter 4: Multitasking by exploitation of intracellular transport functions the many faces of FcRn.

Authors:  E Sally Ward; Raimund J Ober
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

Review 3.  The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases.

Authors:  Alina Sesarman; Gestur Vidarsson; Cassian Sitaru
Journal:  Cell Mol Life Sci       Date:  2010-03-09       Impact factor: 9.261

Review 4.  Pharmacokinetics, pharmacodynamics and physiologically-based pharmacokinetic modelling of monoclonal antibodies.

Authors:  Miroslav Dostalek; Iain Gardner; Brian M Gurbaxani; Rachel H Rose; Manoranjenni Chetty
Journal:  Clin Pharmacokinet       Date:  2013-02       Impact factor: 6.447

5.  Regulation of the Human Fc-Neonatal Receptor alpha-Chain Gene FCGRT by MicroRNA-3181.

Authors:  Daniel C Ferguson; Javier G Blanco
Journal:  Pharm Res       Date:  2018-01-04       Impact factor: 4.200

6.  A neonatal Fc receptor-targeted mucosal vaccine strategy effectively induces HIV-1 antigen-specific immunity to genital infection.

Authors:  Li Lu; Senthilkumar Palaniyandi; Rongyu Zeng; Yu Bai; Xindong Liu; Yunsheng Wang; C David Pauza; Derry C Roopenian; Xiaoping Zhu
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

7.  Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling.

Authors:  Sushil Kumar; Ratnesh Kumar Srivastava; Snahlata Singh; Ajeya Nandi; Gatha Thacker; Hemma Murali; Sabrina Kim; Mary Baldeon; John Tobias; Mario Andres Blanco; Rizwan Saffie; M Raza Zaidi; Satrajit Sinha; Luca Busino; Serge Y Fuchs; Rumela Chakrabarti
Journal:  Nat Cell Biol       Date:  2020-04-13       Impact factor: 28.824

Review 8.  Neonatal Fc receptor: from immunity to therapeutics.

Authors:  Timothy T Kuo; Kristi Baker; Masaru Yoshida; Shuo-Wang Qiao; Victoria G Aveson; Wayne I Lencer; Richard S Blumberg
Journal:  J Clin Immunol       Date:  2010-10-01       Impact factor: 8.317

9.  NFκB induces overexpression of bovine FcRn: a novel mechanism that further contributes to the enhanced immune response in genetically modified animals carrying extra copies of FcRn.

Authors:  Judit Cervenak; Márton Doleschall; Balázs Bender; Balázs Mayer; Zita Schneider; Zoltán Doleschall; Yaofeng Zhao; Zsuzsanna Bősze; Lennart Hammarström; Wolfgang Oster; Imre Kacskovics
Journal:  MAbs       Date:  2013 Nov-Dec       Impact factor: 5.857

10.  The Neonatal Fc Receptor and Complement Fixation Facilitate Prophylactic Vaccine-Mediated Humoral Protection against Viral Infection in the Ocular Mucosa.

Authors:  Derek J Royer; Meghan M Carr; Hem R Gurung; William P Halford; Daniel J J Carr
Journal:  J Immunol       Date:  2017-07-31       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.